Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Critical Reviews in Therapeutic Drug Carrier Systems is Scopus-indexed (Q2, CiteScore 6), WoS SCIE. Published by Begell House Inc..
Checked against the index lists dated .
ISSN 0743-4863Verify ISSN ↗2162-660XVerify ISSN ↗
Publisher: Begell House Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 59 / 191 | 69th | Q2 |
| Pharmacology | 104 / 328 | 68th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1984–present, best quartile Q2, CiteScore 6.
Critical Reviews in Therapeutic Drug Carrier Systems is Q2 in Pharmaceutical Science (rank 59 of 191) and Q2 in Pharmacology (rank 104 of 328), by CiteScore 2025.
Critical Reviews in Therapeutic Drug Carrier Systems is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.469, quartile Q2, with an H-index of 88.
Critical Reviews in Therapeutic Drug Carrier Systems is published by Begell House Inc. Its print ISSN is 0743-4863 and its online ISSN is 2162-660X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Critical Reviews in Therapeutic Drug Carrier Systems has an h-index of 88 and a 2-year mean of 2 citations per paper (OpenAlex). Its Scopus CiteScore is 6, quartile Q2. On 2-year citations it ranks #82 of 177 Scopus journals in Pharmaceutical Science.
Critical Reviews in Therapeutic Drug Carrier Systems published 28 papers in 2025; its busiest recent year was 2018 with 30. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2021–2026), authors are most often from India (69.1%), United States (11.2%) and Pakistan (3.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.